e-learning
resources
Madrid 2019
Tuesday, 01.10.2019
Precision meets immunology in treatment of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma
G. Schwefel (Rostock, Germany), K. Bratke (Rostock, Germany), H. Marchewski (Rostock, Germany), J. Virchow (Rostock, Germany), M. Lommatzsch (Rostock, Germany)
Source:
International Congress 2019 – Precision meets immunology in treatment of airway diseases
Session:
Precision meets immunology in treatment of airway diseases
Session type:
Oral Presentation
Number:
3801
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Schwefel (Rostock, Germany), K. Bratke (Rostock, Germany), H. Marchewski (Rostock, Germany), J. Virchow (Rostock, Germany), M. Lommatzsch (Rostock, Germany). Late Breaking Abstract - Benralizumab treatment reduces the high-affinity IgE receptor on plasmacytoid dendritic cells in patients with severe asthma. 3801
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Upregulation of the high-affinity IgE receptor on plasmacytoid dendritic cells in severe COPD
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Late Breaking Abstract - Benralizumab treatment strongly reduces blood basophils in patients with severe eosinophilic asthma
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Late Breaking Abstract - IgE-FceR1 cross-linking impairs the capacity of plasmacytoid dendritic cells to induce in vitro functional regulatory T cells which can be restored by Omalizumab
Source: International Congress 2019 – Precision meets immunology in treatment of airway diseases
Year: 2019
Late Breaking Abstract - Enhanced IL-33 response in differentiated human TH2 cells carrying the IL-1RL1 asthma risk genotype
Source: Virtual Congress 2021 – Asthma and COPD meets COVID-19: new diagnostic tools and results from clinical trials
Year: 2021
Phenotype of dendritic cells (DCs) stimulated by microbial antigens in COPD patients with frequent and infrequent exacerbations.
Source: International Congress 2017 – Infection and exacerbation science
Year: 2017
Treatment with Omalizumab in adults with severe allergic reduces Fc?I expression on dendritic cells and improves antiviral responses.
Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Year: 2019
Decreased regulation of lung CD8+ T cells by virally-infected macrophages in COPD: Role of PD1/PDL1 axis
Source: International Congress 2015 – Advances from translational research in respiratory infections
Year: 2015
LSC - 2019 - Anti-IL5 in mild asthma alters rhinovirus-induced macrophage, B cell and neutrophil responses
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Circulating mature and progenitor eosinophils in patients with stable asthma express all major traffic related receptors
Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms
Year: 2012
Generation from peripheral blood CD34
+
progenitors of a novel NK-2 subset that produces IL-21 and renders tolerogenic myeloid dendritic cells. A paradox for allergy treatment?
Source: Eur Respir J 2007; 30: Suppl. 51, 135s
Year: 2007
Effect of leukotriene receptor antagonist on expression and variation of TGF-beta in T lymphocyte for mild persistent asthma in children
Source: Annual Congress 2011 - Treating childhood asthma
Year: 2011
Regulatory T cells and L-selectin in severe asthmatic patients treated with mepolizumab.
Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases
Year: 2020
Increase of both blood CXCR3+ and CCR4+ helper T cells associated with severity of asthma
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005
Reduced numbers of circulating CD4
+
CD25
high
FOXP3
+
regulatory T cells in patients with allergic asthma
Source: Annual Congress 2008 - Understanding airway inflammation
Year: 2008
Infiltration of mast cells with increased IgE-receptor expression in peripheral lung of patients with uncontrolled asthma
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
Heterogeneous levels of CD86+CD209+ and CD83+CD209+ dendritic cells in patients with different severity of bronchial asthma
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013
Late Breaking Abstract - Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021
Altered phenotype of blood dendritic cells in patients with acute pneumonia
Source: Annual Congress 2011 - Phagocytes and dendritic cells
Year: 2011
Late Breaking Abstract - Characterization of the immunological profile of COVID-19 patients and correlation of CD4+ and CD8+ T lymphocytes with disease severity during hospitalization.
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021
TLR 7/8 agonist resiquimod alleviates murine allergic asthma through IL-27 production and up regulation of B7-H1 on antigen presenting cells
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept